AKEBIA THERAPEUTICS, INC. (AKBA) Gross margin 2018–2025
AKEBIA THERAPEUTICS, INC. (AKBA) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.3%FY2025 · since FY2018: 96.3% → 83.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.3% | +22.7 pp |
| FY2024 | 60.6% | -1.3 pp |
| FY2023 | 61.9% | -8.8 pp |
| FY2022 | 70.7% | +41.9 pp |
| FY2021 | 28.8% | +29.4 pp |
| FY2020 | -0.6% | -57.2 pp |
| FY2019 | 56.6% | -39.6 pp |
| FY2018 | 96.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross profitAKBA Operating incomeAKBA Operating marginAKBA Operating cash flowAKBA Free cash flowAKBA Capital expendituresAKBA Return on equityAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →